Internal Medicine, Infectious Disease · Atlanta, GA
NPI
1396807103
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2525 Cumberland Parkway, Department of Infectious Disease
Atlanta, GA, 30339
Phone (770) 431-4360
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
236 services
Medicare patients, 2024
114
Average age 65
Drug cost, 2024
$6.6M
4,309 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William T Blake was code 99213 (office e&m - established), 64 times for 44 patients. In total William T Blake billed 236 services in 22 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 64 | 44 | $55.92 | $3,579 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 19 | $95.44 | $3,150 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 19 | $63.44 | $1,776 |
| 99212 Office E&M - Established | Office | 28 | 22 | $38.30 | $1,072 |
| 99214 Office E&M - Established | Office | 20 | 19 | $83.42 | $1,668 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $105.35 | $1,686 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $139.24 | $2,089 |
By year: 2022 $18K for 275 services; 2023 $22K for 293 services; 2024 $17K for 236 services.
Medicare prescription drug claims, 2024
In 2024, the drug William T Blake prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 708 prescriptions and refills. In total William T Blake wrote 4,309 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 708 | 738 | 85 | $2.9M |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 257 | 263 | 25 | $921K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 163 | 179 | 19 | $692K |
| Valacyclovir Valacyclovir Hcl | 139 | 161 | 20 | $3,557 |
| Tivicay Dolutegravir Sodium | 113 | 113 | 15 | $345K |
| Prezcobix Darunavir/Cobicistat | 109 | 113 | 14 | $281K |
| Atorvastatin Calcium Generic | 104 | 161 | 18 | $372 |
| Amlodipine Besylate Generic | 90 | 153 | 22 | $116 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 81 | 93 | Under 11 | $324K |
| Ritonavir Generic | 77 | 104 | 12 | $14K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 75 | 81 | 19 | $320 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 69 | 69 | Under 11 | $2,265 |
| Lisinopril Generic | 64 | 96 | Under 11 | $116 |
| Tamsulosin Hcl Generic | 61 | 79 | Under 11 | $147 |
| Azelastine Hcl Generic | 56 | 70 | Under 11 | $867 |
Brand drugs: - claims; generic drugs: 2,360 claims; opioid claims: 63.
Money and other things of value reported by the companies
No payments from drug or medical device companies to William T Blake were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.